Sep 12, 2023 07:51 PM
PODCAST
China Stories: The Budding Market for Microscopic Organ Testing
Sep.12.2023
Organoid-on-a-chip’ has already been used to evaluate Covid vaccine efficacy in China, but a lack of regulation means the uptake of the niche technology is lagging behind the West.
00:00/00:00
Note: This is an audio narration of a Caixin Global article first published on July 28, 2023.
Contact reporter Zhang Yukun (yukunzhang@caixin.com)
Download our app to receive breaking news alerts and read the news on the go.
Share this article
Open WeChat and scan the QR code
MORE WAYS TO LISTEN
MOST POPULAR
- 1Analysis: Why ByteDance Matters More Than DeepSeek in the Global AI Race
- 2Shanghai Exchange Slaps New Limits on Metal Trading as Prices Soar
- 3Cover Story: China’s Deposit Repricing Tests Banks and Savers as Trillions Come Due
- 4In Depth: How a Lakeside Banquet Reinforced Confidence in Baolide Among China’s Tech Elite
- 5In Depth: Tencent Bets Its AI Future on 28-Year-Old From OpenAI
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas

